Helicobacter pylori: gastric cancer and beyond
Open accessThe DOI matches its Crossref record; 142 of the 144 references it cites were found in a registry or an index.
Abstract
Helicobacter pylori is the dominant species of the human gastric microbiome, and colonization causes a persistent inflammatory response. H. pylori-induced gastritis is the strongest singular risk factor for cancers of the stomach; however, only a small proportion of infected individuals develop malignancy. Carcinogenic risk is modified by strain-specific bacterial components, host responses and/or specific host-microbe interactions. Delineation of bacterial and host mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers as such findings will not only focus the prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, some of these tested pathogens, such as E. coli and H. pylori, are known as initial causes of colon cancers [41,42].”
From Bioprophylactic potential of novel human colostrum probiotics via apoptotic induction of colon cancer cells and cell immune activation (2022) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Correa, P. (1992) · PubMed · Cited by 3,216
Alm, R. A., Ling, L.-S. L., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., et al. (1999) · Nature · doi:10.1038/16495 · Cited by 1,893
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813 · cited 1×
“pylori strain that expressed lex and ley, only bacterial populations recovered from leb-positive mice expressed leb, and this was mediated by a putative galactosyltransferase gene (β‐(1,3)galT)38.”
BackgroundSelf-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607 · cited 1×
“Furthermore, the processing and availability of at least three EGFR ligands, HBEGF, transforming growth factor-α ( TGFα ) and amphiregulin ( AREG ), requires ADAM17 expressio”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435 · cited 1×
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundTranslocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286 · cited 1×
“The product of the terminal gene in the island (CagA) is translocated into and phosphorylated within host epithelial cells following bacterial attachmen”
BackgroundNod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226 · cited 1×
“, where they are sensed by an intracytoplasmic pathogen-recognition molecule nucleotide-binding oligomerization domain-containing protein 1 ( NOD1”
Background
Cited by
Items 101–200 of 1,000
Messina, B., Sardo, F. L., Scalera, S., Memeo, L., Colarossi, C., Mare, M., Blandino, G., Ciliberto, G., Maugeri‐Saccà, M., & Bon, G. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05568-8 · Cited by 122
Intracellular bacteria in cancer—prospects and debates
Schorr, L., Mathies, M., Elinav, E., & Puschhof, J. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00446-9 · Cited by 120
DNA Damage Repair and Bacterial Pathogens
Žgur-Bertok, D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003711 · Cited by 117
“The best studied of these bacteria is Helicobacter pylori, which is associated with gastritis, peptic ulceration, gastric carcinoma, and mucosaassociated lymphoid tissue lymphoma [20].”
Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori
Moonens, K., Gideonsson, P., Subedi, S., Bugaytsova, J. A., Romão, E., Méndez, M., Nordén, J., Fallah, M., Rakhimova, L., Shevtsova, A. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2015.12.004 · Cited by 116
Kim, I.-J., & Blanke, S. R. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00037 · Cited by 114
“…pylori, VacA, vacuolation, mitochondria, apoptosis Helicobacter pylori AND VacA Virulence mechanisms underlying Helicobacter pylori-mediated gastric maladies have remained enigmatic, in part, because disease risk is multifactorial and complex (Compare et al., 2010; Polk and Peek, 2010).”
BackgroundInfluentialInterleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
Haabeth, O. A. W., Lorvik, K. B., Yagita∥, H., Bogen, B., & Corthay, A. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1039763 · Cited by 119
Monteagudo-Mera, A., Arthur, J. C., Jobin, C., Keku, T., Bruno-Barcena, J. M., & Azcarate-Peril, M. A. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0114 · Cited by 112
“The role of Helicobacter in gastric cancer is well-documented (77, 78) and recent reports suggest a potential role of this bacterium in IBD (79–81).”
Helicobacter pyloridrug resistance: therapy changes and challenges
Flores-Treviño, S., Mendoza-Olazarán, S., Bocanegra‐Ibarias, P., Maldonado-Garza, H. J., & Garza‐González, E. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1496017 · Cited by 112
“This risk has been shown to depend on strainspecific bacterial components, host responses, and specific host–microbe interactions [2].”
BackgroundDiet, microbial virulence, and Helicobacter pylori -induced gastric cancer
Cover, T. L., & Peek, Jr. (2013) · Gut Microbes · doi:10.4161/gmic.26262 · Cited by 109
Self-citationOverview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancer.
Jencks, D. S., Adam, J., Borum, M. L., Koh, J. M., Stephen, S., & Doman, D. B. (2018) · Europe PMC (PubMed Central) · Cited by 139
Modulation of autophagy by Helicobacter pylori and its role in gastric carcinogenesis
Greenfield, L. K., & Jones, N. L. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.09.004 · Cited by 115
Lai, Y., Zhang, T., Yin, X., Zhu, C., Du, Y., Li, Z., & Gao, J. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.014 · Cited by 107
“Early in 1994, H. pylori was recognized as a Class I carcinogen, and its role in gastric cancer (GC) development was subsequently well established 10-16 , which our group identified H. pylori as an independent risk factor and predictor of GC risk in a national multicenter study 14 .”
BackgroundChaturvedi, R., Asim, M., Piazuelo, M. B., Yan, F., Barry, D. P., Sierra, J. C., Delgado, A. G., Hill, S., Casero, R. A., Bravo, L. E., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.005 · Cited by 115
Self-citationHelicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation
Tsang, Y. H., Lamb, A., Romero-Gallo, J., Huang, B., Ito, K., Peek, R. M., Ito, Y., & Chen, L. F. (2010) · Oncogene · doi:10.1038/onc.2010.304 · Cited by 101
Self-citationWalker, M. M., & Talley, N. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12666 · Cited by 101
“pylori do not suffer a serious consequence of infection, all will have chronic gastritis, and the risks of progression to ulcer disease,(10) gastric cancer and lymphoma are well known.(11)”
BackgroundGuerra, L., Guidi, R., & Frisan, T. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08125.x · Cited by 100
Chen, C., Wang, Z., Wang, J., Ding, C., Sun, C., Liu, P., Xu, X., Liu, Y., Chen, B., & Gu, B. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-590 · Cited by 105
“For instance, Helicobacter pylori is recognized to be associated with the high risk of gastric cancer and the amount of Fusobacterium nucleatum is associated with the prognosis of colorectal carcinoma patients (10,11).”
BackgroundStructural basis of Lewis b antigen binding by the Helicobacter pylori adhesin BabA
Hage, N., Howard, T. D., Phillips, C., Brassington, C., Overman, R., Debreczeni, J. E., Gellert, P. R., Stolnik, S., Winkler, G. S., & Falcone, F. H. (2015) · Science Advances · doi:10.1126/sciadv.1500315 · Cited by 100
Dias-Jácome, E., Libânio, D., Borges‐Canha, M., Galaghar, A., & Pimentel‐Nunes, P. (2016) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2016.4261/2016 · Cited by 112
How H elicobacter pylori senses, targets and interacts with the gastric epithelium
Keilberg, D., & Ottemann, K. M. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13222 · Cited by 109
Pachathundikandi, S. K., Brandt, S., Madassery, J. V., & Backert, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019614 · Cited by 109
“Injected factors and structural components of the T4SS have been shown to influence membrane dynamics, actin-cytoskeletal rearrangements and the disruption of cell-to-cell junctions as well as proliferative, proinflammatory and anti-apoptotic nuclear responses in the host [17,18,22,23].”
BackgroundFanok, M. H., Sun, A. L., Fogli, L. K., Narendran, V., Eckstein, M., Kannan, K. S., Dolgalev, I., Lazaris, C., Heguy, A., Laird, M. E., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.028 · Cited by 101
“In addition to commensal microbes, pathogenic infections have also been implicated in malignancy (Polk and Peek 2010; Elinav et al. 2013; Belkaid and Hand 2014).”
BackgroundHuman gastric microbiota transplantation recapitulates premalignant lesions in germ-free mice
Kwon, S.-K., Park, J. C., Kim, K. H., Yoon, J., Cho, Y., Lee, B., Lee, J.-J., Jeong, H., Oh, Y., Kim, S., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324489 · Cited by 101
Wizenty, J., & Sigal, M. J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01042-2 · Cited by 106
“…and follows the Correa cascade with its sequential stages of chronic gastritis, atrophy, intestinal metaplasia and dysplasia 94 , whereas the diffuse type occurs via infiltration of individual or clusters of poorly differentiated or signet ring cells that fail to form glandular structures 122,135 .”
Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Terasawa, T., Nishida, H., Kato, K., Miyashiro, I., Yoshikawa, T., Takaku, R., & Hamashima, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109783 · Cited by 102
“In addition to several candidate oncogenic mechanisms [7,8], epidemiologic studies [9–12], have shown the associations between these factors and gastric cancer.”
BackgroundHelicobacter pylori adhesin HopQ disrupts trans dimerization in human CEACAMs
Moonens, K., Hamway, Y., Neddermann, M., Reschke, M. A., Tegtmeyer, N., Kruse, T., Kammerer, R., Mejías‐Luque, R., Singer, B. B., Backert, S., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798665 · Cited by 97
“Infection results in usually asymptomatic gastritis, but prolonged exposure to more virulent strains leads to severe clinical symptoms such as gastric and duodenal ulcers, and malignant transformation resulting in gastric lymphomas and adenocarcinomas (Peek & Blaser, 2002; Polk & Peek, 2010).”
Race, African Ancestry, and Helicobacter pylori Infection in a Low-Income United States Population
Epplein, M., Signorello, L. B., Zheng, W., Peek, R. M., Michel, A., Williams, S. M., Pawlita, M., Correa, P., Cai, Q., & Blot, W. J. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1258 · Cited by 104
“pylori ever develop neoplasia, and cancer risk is dependent upon strainspecific factors as well as host characteristics (8).”
BackgroundSelf-citationLi, F., Yoshizawa, J., Kim, K., Kanjanapangka, J., Grogan, T., Wang, X., Elashoff, D. A., Ishikawa, S., Chia, D., Liao, W., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.290569 · Cited by 100
“pylori, could not be balanced between the groups, as these are known risk factors for GC (5, 24).”
BackgroundInflammation-induced DNA damage and damage-induced inflammation: a vicious cycle
Palmai‐Pallag, T., & Bachrati, C. Z. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.10.001 · Cited by 99
Variations of Tongue Coating Microbiota in Patients with Gastric Cancer
Hu, J., Han, S., Chen, Y., & Zhao-ning, J. (2015) · BioMed Research International · doi:10.1155/2015/173729 · Cited by 99
Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study
Huang, K., Gao, X., Wu, L., Yan, B., Wang, Z., Zhang, X., Peng, L., Yu, J.-F., Sun, G., & Yang, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.640309 · Cited by 98
Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer
Shi, M., Liu, D., Duan, H., Han, C., Wei, B., Qian, L., Chen, C., Guo, L., Hu, M., Yu, M., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-269 · Cited by 93
Potential Role of the Microbiome in Barrett’s Esophagus and Esophageal Adenocarcinoma
Snider, E. J., Freedberg, D. E., & Abrams, J. A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4155-9 · Cited by 100
“pylori negative) [53, 54] Firmicutes (22–30 %) Actinobacteria (8–47 %) Proteobacteria (11–37 %) Bacteroidetes (11–28 %) Fusobacteria (1–4 %) TM7 (\1 %)”
BackgroundConradi, J., Tegtmeyer, N., Woźna, M., Wißbrock, M., Michalek, C., Gagell, C., Cover, T. L., Frank, R., Sewald, N., & Backert, S. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00070 · Cited by 94
“Helicobacter pylori , a gastric pathogen causing gastritis in all infected individuals and more severe gastric disease in 10–15% of cases (Amieva and El-Omar, 2008; Atherton and Blaser, 2009; Polk and Peek, 2010).”
BackgroundZhang, H., Zhang, Y., Song, Z., Li, R., Ruan, H., Liu, Q., & Huang, X. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.151356 · Cited by 94
The Cytolethal Distending Toxin Effects on Mammalian Cells: A DNA Damage Perspective
Bezine, E., Vignard, J., & Mirey, G. (2014) · Cells · doi:10.3390/cells3020592 · Cited by 101
“Helicobacter pylori is a well-known example, associated with gastric carcinoma (reviewed in [120]), downregulation of repair mechanisms and increased mutation frequency [121,122], although this pathogen does not encode any CDT genotoxin.”
BackgroundIslam, N. U., Amin, R., Shahid, M. M., Amin, M. U., Zaib, S., & Iqbal, J. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1791-3 · Cited by 97
“man stomach leads to gastric ulcer or even gastric carcinoma, if left untreated [45].”
BackgroundWei, J., Noto, J. M., Zaika, E. I., Romero–Gallo, J., Correa, P., El-Rifai, W. M., Peek, R. M., & Zaika, A. I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205664109 · Cited by 95
Self-citationHelicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine
Stein, M., Ruggiero, P., Rappuoli, R., & Bagnoli, F. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00328 · Cited by 98
MicroRNA-7/NF-κB signaling regulatory feedback circuit regulates gastric carcinogenesis
Zhao, X.-D., Lu, Y.-Y., Guo, H., Xie, H.-H., He, L.-J., Shen, G.-F., Zhou, J.-F., Li, T., Hu, S.-J., Zhou, L., et al. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201501073 · Cited by 89
Metaplasia in the Stomach—Precursor of Gastric Cancer?
Kinoshita, H., Hayakawa, Y., & Koike, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102063 · Cited by 97
New advances in targeted gastric cancer treatment
Lazăr, D. C., Tăban, S. M., Cornianu, M., Faur, A. C., & Goldiș, A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6776 · Cited by 97
The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management
Alfarouk, K. O., Bashir, A. H. H., Aljarbou, A. N., Ramadan, A. M., Muddathir, A. K., Alhoufie, S. T. S., Hifny, A., Elhassan, G. O., Ibrahim, M. E., Alqahtani, S. S., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00075 · Cited by 98
Soutto, M., Peng, D., Katsha, A. M., Chen, Z., Piazuelo, M. B., Washington, M. K., Belkhiri, A., Correa, P., & El-Rifai, W. M. (2014) · Gut · doi:10.1136/gutjnl-2014-307191 · Cited by 90
How Helicobacter pylori infection controls gastric acid secretion
Smolka, A. J., & Backert, S. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0592-1 · Cited by 96
“infected individuals [1–3].”
BackgroundInfluentialHelicobacter pylori, Cancer, and the Gastric Microbiota
Wroblewski, L. E., & Peek, R. M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41388-4_19 · Cited by 95
Self-citationVacA promotes CagA accumulation in gastric epithelial cells during Helicobacter pylori infection
Abdullah, M., Greenfield, L. K., Bronte-Tinkew, D. M., Capurro, M., Rizzuti, D., & Jones, N. L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37095-4 · Cited by 94
Interplay of the Gastric PathogenHelicobacter pyloriwith Toll-Like Receptors
Pachathundikandi, S. K., Lind, J., Tegtmeyer, N., El-Omar, E. M., & Backert, S. (2015) · BioMed Research International · doi:10.1155/2015/192420 · Cited by 99
A framework for identification of infections that contribute to human obesity
Dhurandhar, N. V. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70274-2 · Cited by 89
Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
Zhou, S., & Chen, X. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s86396 · Cited by 113
“Viral infections by highrisk human papillomavirus (HPV) subtypes, such as HPV16 and HPV18, are causal to the development of cervical, anal, and genital cancers.(29,30) Infections with hepatitis B or C viruses increase the risk of hepatocellular carcinoma;(31) the Epstein–Barr virus can cause lymphomas and nasopharynge…”
Recent developments and innovations in gastric cancer
Mihmanlı, M., İlhan, E., İdiz, U. O., Alemdar, A., & Demir, U. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i17.4307 · Cited by 94
Suárez, G., Romero–Gallo, J., Piazuelo, M. B., Wang, G., Maier, R. J., Forsberg, L. S., Azadi, P., Zuleta, M. A. G., Correa, P., & Peek, R. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2291 · Cited by 87
Self-citationEpigenetic changes in gastric cancer induction by Helicobacter pylori
Yousefi, B., Mohammadlou, M., Abdollahi, M., Farrokhi, A. S., Karbalaei, M., Keikha, M., Kokhaei, P., Valizadeh, S., Rezaiemanesh, A., Arabkari, V., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28925 · Cited by 89
“Most patients with gastric carcinoma are asymptomatic and may be at an advanced stage of the disease during diagnosis (Polk & Peek, 2010).”
BackgroundHsieh, H., Yu, M., Cheng, L., Chu, M.-Y., Huang, T.-H., Yeh, T., & Tsai, M.-M. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i11.1139 · Cited by 89
Tegtmeyer, N., Wittelsberger, R., Hartig, R., Weßler, S., Martínez-Quiles, N., & Backert, S. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.05.007 · Cited by 85
Controversies in the Treatment of Local and Locally Advanced Gastric and Esophageal Cancers
Cohen, D. J., & Leichman, L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7765 · Cited by 88
Analysis of Surface-Exposed Outer Membrane Proteins in Helicobacter pylori
Voss, B. J., Gaddy, J. A., McDonald, W. H., & Cover, T. L. (2014) · Journal of Bacteriology · doi:10.1128/jb.01768-14 · Cited by 84
Kim, I.-J., Lee, J., Oh, S. J., Yoon, M., Jang, S.-S., Holland, R. L., Reno, M. L., Hamad, M. N., Maeda, T., Chung, H. J., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.04.006 · Cited by 86
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
BackgroundFederico, A., Nardone, G., Gravina, A. G., Iovene, M. R., Miranda, A., Compare, D., Pilloni, A. P., Rocco, A., Ricciardiello, L., Marmo, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.043 · Cited by 83
Pachathundikandi, S. K., Tegtmeyer, N., & Backert, S. (2013) · Gut Microbes · doi:10.4161/gmic.27001 · Cited by 90
“These factors also appear to play a key role in the pathophysiology of gastric disease development and their importance has been investigated in animal models which mimic human gastric neoplasia.(3,4) It can be expected that more genetic polymorphisms both in the host and in H.”
BackgroundInfluentialTegtmeyer, N., Moodley, Y., Yamaoka, Y., Pernitzsch, S. R., Schmidt, V., Rivas-Traverso, F., Schmidt, T. P., Rad, R., Yeoh, K. G., Ho, B., et al. (2015) · Molecular Microbiology · doi:10.1111/mmi.13276 · Cited by 82
Tang, C., Lin, X., Wu, S., Liang, Q., Li, Y., Gao, Y., & Ge, Z. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.02.007 · Cited by 82
From Beyond the Pale to the Pale Riders: The Emerging Association of Bacteria with Oral Cancer
Fitzsimonds, Z. R., Hernandez, C. J. R., Bagaitkar, J., & Lamont, R. J. (2020) · Journal of Dental Research · doi:10.1177/0022034520907341 · Cited by 80
“…of the importance of viruses in carcinogenesis, the idea fell into abeyance, and it was not until Helicobacter pylori was established as a cause of gastric cancer in the 1990s that the potential for a carcinogenic role of bacteria became rehabilitated (Polk and Peek 2010; Whitmore and Lamont 2014).”
BackgroundZhang, X., Chen, X., Guo, Y., Gao, G., Wang, D., Wu, Y., Liu, J., Liang, G., Zhao, Y., & Wu, F. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102059 · Cited by 79
Gan, J., Ke, X., Jiang, J., Dong, H., Yao, Z., Lin, Y., Lin, W., Wu, X., Yan, S., Zhuang, Y.-X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618582114 · Cited by 85
“Infection with the pathogen Helicobacter pylori, which triggers chronic gastritis, remains the strongest single risk factor for human GC (6).”
BackgroundAssociation between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
Zhang, S., Cai, S., & Ma, Y. (2018) · Journal of Cancer · doi:10.7150/jca.24048 · Cited by 82
Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation
Krejsgaard, T., Willerslev-Olsen, A., Lindahl, L. M., Bonefeld, C. M., Koralov, S. B., Geisler, C., Wasik, M. A., Gniadecki, R., Kilian, M., Iversen, L., et al. (2014) · Blood · doi:10.1182/blood-2014-01-551184 · Cited by 80
Rolig, A. S., Cech, C., Ahler, E., Carter, J. E., & Ottemann, K. M. (2013) · Infection and Immunity · doi:10.1128/iai.00044-13 · Cited by 77
“The bacterial gastric pathogen Helicobacter pylori colonizes more than half of the world’s population (1, 2).”
BackgroundPiao, J., Lee, H. G., Kim, S., Kim, D., Han, H., Ngo, H., Park, S., Woo, J., Lee, J., Na, H., et al. (2016) · Helicobacter · doi:10.1111/hel.12298 · Cited by 81
Impact of the Microbiota and Gastric Disease Development by Helicobacter pylori
Alarcón, T., Llorca, L., & Perez-Perez, G. (2017) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-50520-6_11 · Cited by 82
Farzi, N., Yadegar, A., Aghdaei, H. A., Yamaoka, Y., & Zali, M. R. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.02.017 · Cited by 76
The Role of microRNAs in Helicobacter pylori Pathogenesis and Gastric Carcinogenesis
Noto, J. M., & Peek, R. M. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2011.00021 · Cited by 80
“Following its injection into host cells, CagA exerts a wide range of phosphorylation-dependent and independent effects, such as cytoskeletal rearrangements, disruption of cell polarity, and mitogenic and proinflammatory responses (Polk and Peek, 2010).”
InfluentialSelf-citationSala, N., Muñoz, X., Travier, N., Agudo, A., Duell, E. J., Moreno, V. R., Overvad, K., Tjønneland, A. M., Boutron‐Ruault, M., Clavel‐Chapelon, F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26243 · Cited by 76
Oh, K., Ko, E., Kim, H. S., Park, A. K., Moon, H., Noh, D., & Lee, D. (2011) · Breast Cancer Research · doi:10.1186/bcr3034 · Cited by 79
“Persistent Helicobacter pylori infection is associated with gastric cancer [3].”
BackgroundTseng, C.-H., Lin, J., Ho, H. J., Lai, Z.-L., Wang, C., Tang, S., & Wu, C. (2016) · Scientific Reports · doi:10.1038/srep20701 · Cited by 76
Echizen, K., Horiuchi, K., Aoki, Y., Yamada, Y. M. A., Minamoto, T., Oshima, H., & Oshima, M. (2019) · Oncogene · doi:10.1038/s41388-019-0702-0 · Cited by 77
A model for cancer-suppressive inflammation
Haabeth, O. A. W., Bogen, B., & Corthay, A. (2012) · OncoImmunology · doi:10.4161/onci.21542 · Cited by 80
“This hypothesis is based on the observation that acute inflammation may cure cancer,(108-110,112-114) whereas several chronic inflammatory diseases predispose to cancer.(8-10) However, there are indications that chronic inflammation may not always be detrimental.”
BackgroundClinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma
Ferreira, R. M., Machado, J. C., & Figueiredo, C. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.09.004 · Cited by 82
“Persistent infection with the stomach colonizing bacterium Helicobacter pylori is the major trigger for the development of sporadic gastric carcinoma, of both intestinal and diffuse types [4,5].”
BackgroundInfluentialPancreatic cancer: Helicobacter pylori colonization, N‐Nitrosamine exposures, and ABO blood group
Risch, H. A. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20826 · Cited by 86
“mucins and directly to mucosal epithelium [74].”
BackgroundHelicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease
Smolka, A. J., & Schubert, M. L. (2017) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-50520-6_10 · Cited by 88
Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori
Suganuma, M., Watanabe, T., Yamaguchi, K., Takahashi, A., & Fujiki, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.027 · Cited by 74
“pylori infection [1–4], and it is well understood that persistent H.”
BackgroundMicroRNA Modulation of Host Immune Response and Inflammation Triggered by Helicobacter pylori
Săsăran, M. O., Meliţ, L. E., & Dobru, E. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031406 · Cited by 76
“pylori strains, being considered a strong inducer of the NF-kB [39,41].”
BackgroundNoto, J. M., Piazuelo, M. B., Shah, S. C., Romero–Gallo, J., Hart, J. L., Di, C., Carmichael, J. D., Delgado, A. G., Halvorson, A. E., Greevy, R. A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci147822 · Cited by 80
“pylori strains that harbor the cag island induce more severe gastric injury and augment the risk for gastric cancer compared with cag-negative strains (2).”
BackgroundSelf-citationKim, J. K., Noh, J. H., Eun, J. W., Jung, K. H., Bae, H. J., Shen, Q., Kim, M. G., Chang, Y. G., Kim, S.-J., Park, W. S., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0332 · Cited by 76
“Over the last few years, several studies contributed toward an understanding of the molecular causes of gastric cancer, thereby facilitating its early diagnosis and improved curability (2, 3).”
BackgroundTibbs, T. N., Lopez, L. R., & Arthur, J. C. (2019) · Microbial Cell · doi:10.15698/mic2019.08.685 · Cited by 68
“pylori infection only progresses to malignancy in a subset of infected individuals; however, it is postulated that host immune responses and the genetics of both host and microbiota contribute to neoplastic development [103].”
BackgroundModulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy
Wu, J., Wang, S., Zheng, B. J., Qiu, X., Wang, H., & Chen, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669150 · Cited by 83
“Gut Microbiota and Gastrointestinal Cancer Gut microbiota has a great influence on gastrointestinal cancer (38, 39).”
BackgroundShi, M., Yang, Z., Hu, M., Liu, D., Hu, Y., Qian, L., Zhang, W., Chen, H., Guo, L., Yu, M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202364 · Cited by 73
“However, its effectiveness in gastric cancer has not yet been studied systematically because trastuzumab-based therapy in Her2-overexpressing gastric cancer was just started (2, 4).”
BackgroundEnemy attraction: bacterial agonists for leukocyte chemotaxis receptors
Bloes, D. A., Kretschmer, D., & Peschel, A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3390 · Cited by 75
Nagy, T. A., Wroblewski, L. E., Wang, D., Piazuelo, M. B., Delgado, A., Romero–Gallo, J., Noto, J. M., Israel, D. A., Ogden, S. R., Correa, P., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.004 · Cited by 78
Self-citationMagalhães, A., Rossez, Y., Masselot, C. R., Maes, E., Gomes, J., Shevtsova, A. A., Bugaytsova, J. A., Borén, T., & Reis, C. A. (2016) · Scientific Reports · doi:10.1038/srep25575 · Cited by 73
Pathogen mimicry of host protein-protein interfaces modulates immunity
Guven‐Maiorov, E., Tsai, C., & Nussinov, R. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.06.004 · Cited by 73
Relationship between Helicobacter pylori infection and GERD.
Scida, S., Russo, M., Miraglia, C., Leandro, G., Franzoni, L., Meschi, T., Angelis, G. L. D., & Mario, F. D. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i8-s.7918 · Cited by 82
The potential role of the microbiota in prostate cancer pathogenesis and treatment
Pernigoni, N., Guo, C. W., Gallagher, L., Yuan, W., Colucci, M., Troiani, M., Liu, L., Maraccani, L., Guccini, I., Migliorini, D., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00795-2 · Cited by 77
“responses, promote gastric epithelial inflammatory cytokine release, modulate apoptosis pathways and activate oncogenic pathways such as Wnt–β-catenin that drive oncogenic transformation 18 .”
BackgroundInterleukin-1β induced by Helicobacter pylori infection enhances mouse gastric carcinogenesis
Shigematsu, Y., Niwa, T., Rehnberg, E., Toyoda, T., Yoshida, S., Mori, A., Wakabayashi, M., Iwakura, Y., Ichinose, M., Kim, Y.-J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.034 · Cited by 72
“At the same time, only a minority ( 3%) of HP-infected individuals develops gastric cancer after many years [5,6].”
BackgroundGargi, A., Reno, M. L., & Blanke, S. R. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00124 · Cited by 72
Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis
Wang, A.-M., Huang, T.-T., Hsu, K.-W., Huang, K.-H., Fang, W.-L., Yang, M.-H., Lo, S., Chi, C., Lin, J.-J., & Yeh, T.-S. (2014) · OncoTarget · doi:10.18632/oncotarget.2073 · Cited by 76
The Role of ErbB Receptors in Infection
Ho, J., Moyes, D. L., Tavassoli, M., & Naglik, J. R. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.04.009 · Cited by 75
“pylori infections are strongly linked to the dysregulation of EGFR ligands and/or transactivation of EGFR (reviewed in [103]).”
Cancer type classification using plasma cell-free RNAs derived from human and microbes
Chen, S., Jin, Y., Wang, S., Xing, S., Wu, Y., Tao, Y., Ma, Y., Zuo, S., Liu, X., Hu, Y., et al. (2022) · eLife · doi:10.7554/elife.75181 · Cited by 74
Metadata
- Authors
- Polk, D. B., & Peek, R. M.
- Affiliations
- University of Southern California (US)
- Vanderbilt University (US)
- Corresponding author
- Peek, Richard M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 403-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2957472
- OpenAlex
- W1998630067
- Cited by
- 1,158
- References
- 144
- Citations by year
- 2026: 66 · 2025: 71 · 2024: 74 · 2023: 86 · 2022: 74 · 2021: 80 · 2020: 73 · 2019: 66 · 2018: 72 · 2017: 58 · 2016: 83 · 2015: 68 · 2014: 70 · 2013: 79 · 2012: 72
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA077955, P01CA116087)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058587)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Helicobacter pylori, gastric adenocarcinoma, inflammatory carcinogenesis, host-microbe interactions, gastritis, gastric microbiota, cancer risk factors, cancer prevention
- MeSH terms
- Animals, Humans, Risk Factors, Stomach Neoplasms, Signal Transduction, Helicobacter pylori, Helicobacter Infections, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.